Brief: Resonance Health Says Contracted For Two New Clinical Trials
11/11/2022 24:19
Nov 11 (Reuters) - Resonance Health RHT.AX :
* RESONANCE HEALTH CONTRACTED FOR TWO NEW CLINICAL TRIALS
* VALUE OF NEW CONTRACTS IS UP TO AU $1.5M
* CONTRACTED WITH 2 NEW PHARMACEUTICAL CUSTOMERS TO PROVIDE
FERRISCAN, CARDIAC-T2 & RELATED ANALYSIS SERVICES FOR CLINICAL
TRIALS
Source text for Eikon: ID:nASX76pTFM
Further company coverage: RHT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Resonance Health
See all newsAustralia's Resonance Health jumps on FY26 forecast hike
Brief: Resonance Health Expects FY26 Underlying EBITDA A$2.6 Mln
Brief: Resonance Health Says Martin Blake Retires As Chair
Brief: Resonance Health Contracted For Clinical Drug Trial Worth A$13.775 Mln
Brief: Resonance Seeks Trading Halt Pending Announcement On Execution Of Contract For Services For Clinical Trial By Pharma Co